Correlation Between Pulmatrix and Adial Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and Adial Pharmaceuticals, you can compare the effects of market volatilities on Pulmatrix and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Adial Pharmaceuticals.

Diversification Opportunities for Pulmatrix and Adial Pharmaceuticals

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Pulmatrix and Adial is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Adial Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of Pulmatrix i.e., Pulmatrix and Adial Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pulmatrix and Adial Pharmaceuticals

Given the investment horizon of 90 days Pulmatrix is expected to generate 1.55 times more return on investment than Adial Pharmaceuticals. However, Pulmatrix is 1.55 times more volatile than Adial Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Adial Pharmaceuticals is currently generating about -0.3 per unit of risk. If you would invest  765.00  in Pulmatrix on November 3, 2024 and sell it today you would earn a total of  5.00  from holding Pulmatrix or generate 0.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Pulmatrix  vs.  Adial Pharmaceuticals

 Performance 
       Timeline  
Pulmatrix 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.
Adial Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adial Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pulmatrix and Adial Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pulmatrix and Adial Pharmaceuticals

The main advantage of trading using opposite Pulmatrix and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.
The idea behind Pulmatrix and Adial Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bonds Directory
Find actively traded corporate debentures issued by US companies
Transaction History
View history of all your transactions and understand their impact on performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets